×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
Vision
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
Vision
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: Alpha-Synuclein-Targeting Therapies
therapeutic
1,215 words
KG: Alpha-Synuclein-Targeting Therapies
2026-03-23
kind:therapeutic
section:therapeutics
state:published
Contents
Alpha-Synuclein-Targeting Therapies
💊
Therapeutic Info
Name
Alpha-Synuclein-Targeting Therapies
Summary
Page for Alpha-Synuclein-Targeting Therapies
Knowledge Graph
Related Hypotheses (30)
Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro
Score: 0.54
Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar
Score: 0.53
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.41
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.60
TREM2-mediated microglial tau clearance enhancement
Score: 0.58
Microbial Inflammasome Priming Prevention
Score: 0.65
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.77
Vagal Afferent Microbial Signal Modulation
Score: 0.57
Smartphone-Detected Motor Variability Correction
Score: 0.65
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.49
Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.50
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.49
Vocal Cord Neuroplasticity Stimulation
Score: 0.58
TREM2-Dependent Microglial Senescence Transition
Score: 0.83
APOE-Dependent Autophagy Restoration
Score: 0.72
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.69
Competitive APOE4 Domain Stabilization Peptides
Score: 0.66
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.63
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.62
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.62
Phase-Separated Organelle Targeting
Score: 0.60
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.58
APOE Isoform Expression Across Glial Subtypes
Score: 0.57
APOE-TREM2 Interaction Modulation
Score: 0.57
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.57
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.55
Gut Barrier Permeability-α-Synuclein Axis Modulation
Score: 0.55
APOE Isoform Conversion Therapy
Score: 0.53
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.52
DNMT1-Targeting Antisense Oligonucleotide Reset
Score: 0.44
Show 25 more
Related Analyses (19)
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · completed
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · completed
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · completed
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · completed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed
GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
Senolytic therapy for age-related neurodegeneration
neurodegeneration · completed
Show 14 more
Related Experiments (14)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Longitudinal TLR2 reporter gene study in α-synuclein mice
validation · proposed · Score: 0.90
Dexamethasone treatment study in α-synuclein mice
validation · proposed · Score: 0.85
TLR expression in α-synuclein overexpressing mice
validation · proposed · Score: 0.80
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40
tACS Connectivity Trial in Early Alzheimer's
clinical · proposed · Score: 0.40
Microbiome-Gut Barrier Signatures in ALS — Experiment Design
clinical · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40
NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Show 9 more
See Also (15)
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 3 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 3 hypotheses
Therapeutic Targets in Neurodegeneration
mechanism · Pages share 3 hypotheses
Tau Seeding and Propagation Pathway
mechanism · Pages share 3 hypotheses
Sex Differences in Neurodegeneration
mechanism · Pages share 3 hypotheses
Senescent Cell Clearance in Neurodegeneration
mechanism · Pages share 3 hypotheses
Retinal Degeneration Pathway in Neurodegeneration
mechanism · Pages share 3 hypotheses
Microglial Priming Pathway in Neurodegeneration
mechanism · Pages share 3 hypotheses
Lipid Metabolism Dysregulation in Neurodegeneration
mechanism · Pages share 3 hypotheses
IL-1 Signaling Pathway in Neurodegeneration
mechanism · Pages share 3 hypotheses
HMGB1 Signaling in Neurodegeneration
mechanism · Pages share 3 hypotheses
gp130/IL-6 Family Cytokine Signaling in Neurodegenerati
mechanism · Pages share 3 hypotheses
Galectin-3 Mechanism in Neurodegeneration
mechanism · Pages share 3 hypotheses
Endosomal-Lysosomal Pathway in Neurodegeneration
mechanism · Pages share 3 hypotheses
Dystrophic Neurites in Neurodegeneration
mechanism · Pages share 3 hypotheses
Show 10 more